Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting-Reference-Cited by-同舟云学术

Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting

Published:2015-03 Issue:3 Volume:65 Page:197-202
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Kawai Hideki^ORCID,Watanabe Eiichi,Yamamoto Mayumi,Harigaya Hiroto,Sano Kan,Takatsu Hidemaro,Muramatsu Takashi,Naruse Hiroyuki,Sobue Yoshihiro,Motoyama Sadako,Sarai Masayoshi,Takahashi Hiroshi,Arakawa Tomoharu,Kan Shino,Sugiura Atsushi,Murohara Toyoaki,Ozaki Yukio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

3. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy;McFadden;Lancet,2004

4. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);European Heart Rhythm Association;Eur Heart J,2010

5. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Guyatt;Chest,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new‐generation drug‐eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)‐4 trial;Clinical Cardiology;2023-05-16

2. Rationale and Design of Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS);Circulation Reports;2022-12-09

3. Comparison of effects of triple antithrombotic therapy and dual antiplatelet therapy on long-term outcomes of acute myocardial infarction;Heart and Vessels;2020-10-08

4. Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention;ACTA CARDIOL SIN;2019

5. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta‐analysis;Journal of Cardiovascular Electrophysiology;2019-08-29